RAPT Therapeutics Email Format
Biotechnology ResearchCalifornia, United States51-200 Employees
RAPT Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California. The organization focuses on immunology-driven research to discover, develop, and commercialize therapies for inflammatory and immunological diseases. It seeks to modulate the immune responses that underlie these conditions, drawing on deep immunology expertise. Within the biotechnology research sector, RAPT targets patients affected by inflammatory and immunological diseases. A notable development is the RPT904 program, for which the company holds worldwide rights excluding the Jemincare Territory under a license established in 2024. In January 2026, RAPT participated in the 44th Annual J.P. Morgan Healthcare Conference.